FDA clears 1st treatment for peanut allergy in childrenThe FDA has approved Palforzia, the first treatment for peanut allergy in children. Coronavirus fears drive shortages of respiratory masks, sanitizersThe spread of the coronavirus is leading to a shortage of masks and sanitizers in retailers nationwide. BioMotiv, Bristol-Myers Squibb launch Anteros Pharmaceuticals Anteros Pharmaceuticals will focus on inflammatory diseases. Independent Pharmacy Conference celebrates 10 years The Independent Pharmacy Conference, now in its 10th year, provides a meeting place for independent owners, industry leaders and vendors. Lupin gets FDA blessing for generic Arava Leflunomide tablets had a market value of roughly $44 million, according to December 2019 IQVIA data. Fresenius Kabi introduces Glucagon Emergency Kit Fresenius Kabi's glucagon emergency kit provides a treatment for severe hypoglycemia in pediatric and adult patients with diabetes. McKesson sees revenue gains in Q3 McKesson's pharmaceutical and specialty solutions segment saw Q3 2020 revenue up 6% over Q3 2019, totaling $46.9 billion. Towa closes acquisition of Esteve's generics division Breckenridge is among the companies included in the acquisition. NACDS' Anderson addresses coronavirus and pharmacists' readiness in op-ed Pharmacists are committed to responding to public health emergencies such as the coronavirus, and patients' needs every day, NACDS' Steve Anderson writes in an op-ed on Medium. Augia Pharma gets FDA nod for generic Rheumatrex Methotrexate tablets have a market value of roughly $98 million for the 12 months ended December 2019, according to IQVIA. First Previous 411 412 413 414 415 Next Last